BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8009257)

  • 1. Moderate Paget's disease treated with pamidronate: comparison of various infusion rates for a 60-mg single dose.
    Thiebaud D; Portmann L; Burckhardt P
    Semin Arthritis Rheum; 1994 Feb; 23(4):279. PubMed ID: 8009257
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-term efficacy of intravenous pamidronate in Paget's disease of bone.
    Grauer A; Klar B; Scharla SH; Zieglar R
    Semin Arthritis Rheum; 1994 Feb; 23(4):283-4. PubMed ID: 8009261
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of Paget's disease of bone with single-dose intravenous pamidronate.
    Watts RA; Skingle S; Bhambani M; Pountain G; Crisp AJ
    Semin Arthritis Rheum; 1994 Feb; 23(4):281. PubMed ID: 8009259
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of Paget's disease of bone with single dose intravenous pamidronate.
    Watts RA; Skingle SJ; Bhambhani MM; Pountain G; Crisp AJ
    Ann Rheum Dis; 1993 Aug; 52(8):616-8. PubMed ID: 8215628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-day intravenous pamidronate in Paget's disease.
    Hooper MJ; Clifton-Bligh P; Marel GM; Lang FV; Tancred J; McDowall D; Forman L
    Semin Arthritis Rheum; 1994 Feb; 23(4):276-7. PubMed ID: 8009255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pamidronate is effective for Paget's disease of bone refractory to conventional therapy.
    Wimalawansa SJ; Gunasekera RD
    Calcif Tissue Int; 1993 Oct; 53(4):237-41. PubMed ID: 8275351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous pamidronate in Paget's disease--response is dependent on radiographic and biochemical severity.
    Stuckey BG; Gutteridge DH; Stewart GO; Prince RL; Ward LC; Kent GN; Prince RI; Retallack RW; Bhagat CI; Nicholson GC
    Semin Arthritis Rheum; 1994 Feb; 23(4):286. PubMed ID: 8009263
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of Paget's disease of bone.
    Anderson D; Cantrill JC
    Br Med J (Clin Res Ed); 1988 Jan; 296(6617):291. PubMed ID: 3124919
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of Paget's disease with intermittent low-dose infusions of disodium pamidronate (APD).
    Stone MD; Hawthorne AB; Kerr D; Webster G; Hosking DJ
    J Bone Miner Res; 1990 Dec; 5(12):1231-5. PubMed ID: 2075835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical, biochemical, hematologic, and radiographic responses in Paget's disease following intravenous pamidronate disodium: a 2-year study.
    Gutteridge DH; Retallack RW; Ward LC; Stuckey BG; Stewart GO; Prince RL; Kent GN; Bhagat CI; Price RI; Thompson RI; Nicholson GC
    Bone; 1996 Oct; 19(4):387-94. PubMed ID: 8894145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous aminopropylidene bisphosphonate in the treatment of severe polyostotic Paget's disease of bone.
    Fritz P; Lioté F; Kuntz D
    Semin Arthritis Rheum; 1994 Feb; 23(4):282. PubMed ID: 8009260
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical experience with pamidronate in the treatment of Paget's disease of bone.
    Gallacher SJ; Boyce BF; Patel U; Jenkins A; Ralston SH; Boyle IT
    Ann Rheum Dis; 1991 Dec; 50(12):930-3. PubMed ID: 1768163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of intravenous pamidronate therapy on Paget's disease of bone.
    Bombassei GJ; Yocono M; Raisz LG
    Am J Med Sci; 1994 Oct; 308(4):226-33. PubMed ID: 7942981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paget's disease of bone: five regimens of pamidronate treatment.
    Pepersack T; Karmali R; Gillet C; François D; Fuss M
    Clin Rheumatol; 1994 Mar; 13(1):39-44. PubMed ID: 8187442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in serum HDL and LDL cholesterol in patients with Paget's bone disease treated with pamidronate.
    Montagnani A; Gonnelli S; Cepollaro C; Campagna MS; Franci MB; Pacini S; Gennari C
    Bone; 2003 Jan; 32(1):15-9. PubMed ID: 12584031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of appendicular bone loss in Paget's disease following treatment with intravenous pamidronate disodium.
    Stewart GO; Gutteridge DH; Price RI; Ward L; Retallack RW; Prince RL; Stuckey BG; Kent GN; Bhagat CI; Dhaliwal SS
    Bone; 1999 Feb; 24(2):139-44. PubMed ID: 9951784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A single infusion of the bisphosphonate AHPrBP (APD) as treatment of Paget's disease of bone.
    Thiébaud D; Jaeger P; Gobelet C; Jacquet AF; Burckhardt P
    Am J Med; 1988 Aug; 85(2):207-12. PubMed ID: 3261129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perspectives: a practical guide to the use of pamidronate in the treatment of Paget's disease.
    Siris ES
    J Bone Miner Res; 1994 Mar; 9(3):303-4. PubMed ID: 8191921
    [No Abstract]   [Full Text] [Related]  

  • 19. Ibandronate treatment in Paget's disease of bone.
    Grauer A; Heichel S; Knaus J; Dosch E; Ziegler R
    Bone; 1999 May; 24(5 Suppl):87S-89S. PubMed ID: 10321936
    [No Abstract]   [Full Text] [Related]  

  • 20. Intravenous pamidronate: evolution of an effective treatment strategy.
    Anderson DC; Richardson PC; Brown JK; Freemont AJ; Hollis S; Denton J; Buckler HM; Hargreaves S; Cantrill JA
    Semin Arthritis Rheum; 1994 Feb; 23(4):273-5. PubMed ID: 8009254
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.